Yoshiaki Nakamura Selected Research

Yoshiaki Nakamura Research Topics

Disease

59	Neoplasms (Cancer) 04/2024 - 03/2011
30	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 11/2018
24	Stomach Neoplasms (Stomach Cancer) 03/2024 - 01/2018
14	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2003
10	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2015
7	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2024 - 01/2020
5	Disease Progression 04/2024 - 01/2003
5	Microsatellite Instability 01/2022 - 11/2018
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2024 - 06/2022
3	Adenocarcinoma 10/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2022
2	Carcinoma (Carcinomatosis) 01/2022 - 12/2010
2	Fever (Fevers) 12/2021 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 07/2021 - 01/2017
2	Neutropenia 01/2021 - 12/2019
2	Residual Neoplasm 12/2020 - 01/2019
2	Triple Negative Breast Neoplasms 01/2019 - 07/2012
1	Squamous Cell Carcinoma of Head and Neck 02/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Vascular Remodeling 01/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Esophageal Squamous Cell Carcinoma 10/2022
1	Lymphatic Metastasis 04/2022
1	Amyloid Plaque 01/2022

Drug/Important Bio-Agent (IBA)

20	Circulating Tumor DNAIBA 04/2024 - 11/2018
15	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2018
9	Immune Checkpoint InhibitorsIBA 02/2024 - 11/2018
9	Trastuzumab (Herceptin)FDA Link 09/2023 - 12/2010
8	NivolumabIBA 02/2024 - 01/2019
7	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2020
6	Hormones (Hormone)IBA 04/2024 - 01/2016
6	human ERBB2 proteinIBA 12/2022 - 11/2014
6	pembrolizumabIBA 01/2022 - 01/2020
5	ErbB Receptors (EGF Receptor)IBA 01/2024 - 11/2018
4	Cell-Free Nucleic AcidsIBA 03/2024 - 12/2019
4	trifluridine tipiracil drug combinationIBA 11/2023 - 12/2019
4	pertuzumabIBA 07/2023 - 11/2021
4	Monoclonal AntibodiesIBA 06/2021 - 01/2019
4	Irinotecan (Camptosar)FDA LinkGeneric 06/2021 - 01/2020
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2024 - 07/2012
3	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 07/2012
3	regorafenibIBA 02/2024 - 01/2021
3	lenvatinibIBA 01/2022 - 01/2020
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2021 - 02/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 12/2010
2	niraparibIBA 04/2024 - 12/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024 - 12/2022
2	AntibodiesIBA 03/2024 - 01/2022
2	Bispecific AntibodiesIBA 03/2024 - 07/2023
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
2	RamucirumabIBA 11/2023 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2022
2	Docetaxel (Taxotere)FDA Link 12/2022 - 12/2021
2	trastuzumab deruxtecanIBA 06/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2018
2	ParaffinIBA 01/2022 - 01/2018
2	Tumor Biomarkers (Tumor Markers)IBA 10/2021 - 07/2021
2	Capecitabine (Xeloda)FDA Link 07/2021 - 02/2019
2	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2019
2	Estrogen ReceptorsIBA 01/2021 - 11/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2020
2	Taxoids (Taxanes)IBA 01/2020 - 09/2017
2	AnthracyclinesIBA 09/2017 - 03/2012
2	Aromatase InhibitorsIBA 11/2016 - 03/2011
1	Epidermal Growth Factor (EGF)IBA 04/2024
1	abemaciclibIBA 04/2024
1	Indicators and Reagents (Reagents)IBA 03/2024
1	Chimeric Antigen ReceptorsIBA 03/2024
1	ClaudinsIBA 03/2024
1	zolbetuximabIBA 03/2024
1	TAS-116IBA 02/2024
1	LigandsIBA 02/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023
1	Trifluridine (Viroptic)FDA LinkGeneric 10/2023
1	tipiracilIBA 10/2023
1	tucatinibIBA 09/2023
1	eribulin FDA Link 01/2023
1	ProteomeIBA 12/2022
1	Fluorouracil (Carac)FDA LinkGeneric 10/2022
1	PlatinumIBA 10/2022
1	Notch ReceptorsIBA 10/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	alectinibIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022

Therapy/Procedure

39	Therapeutics 04/2024 - 01/2003
21	Drug Therapy (Chemotherapy) 03/2024 - 12/2010
10	Precision Medicine 03/2024 - 09/2018
8	Adjuvant Chemotherapy 01/2024 - 09/2017
5	Immunotherapy 02/2024 - 01/2019
3	Genomic Medicine 11/2022 - 09/2018
3	Hepatectomy 12/2021 - 05/2002
2	Molecular Targeted Therapy 01/2022 - 01/2022
2	Neoadjuvant Therapy 01/2022 - 01/2019
2	Gastrectomy 12/2021 - 02/2019
1	Chemoradiotherapy 10/2022
1	Conformal Radiotherapy 10/2022
1	Aftercare (After-Treatment) 04/2022
1	Lymph Node Excision (Lymph Node Dissection) 04/2022